Related Articles
Leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan as individualized first-line therapy based on a drug sensitivity test
High expression of P21‑activated kinase 5 protein is associated with poor survival in gastric cancer
FKBP3 mediates oxaliplatin resistance in colorectal cancer cells by regulating HDAC2 expression
The role of MRP1 in the multidrug resistance of colorectal cancer
Prognostic implications of survivin and lung resistance protein in advanced non-small cell lung cancer treated with platinum-based chemotherapy